TOKYO -- Taisho Pharmaceutical Holdings on Friday announced an offer by management to take the company private, looking to facilitate a pivot toward online and overseas sales of its mainstay over-the-counter drugs amid a weak domestic market.
Business deals
Japanese drugmaker Taisho eyes $5bn management buyout
Family of top shareholders eyes delisting for long-term turnaround as costs mount
Taisho is Japan's largest over-the-counter medication company, with products such as the Lipovitan energy drink line. (Photo by Nikkei)
Read Next
Latest on Business deals
